Jonathan R. Green

4.0k citations

41 papers · 3.2k indexed · 1 hit paper · h-index 22

Impact in

Orthopedics and Sports Medicine top 0.5%
- Bone and Joint Diseases
- Bone health and osteoporosis research
Oncology top 1%
- Bone health and treatments
- Cancer Diagnosis and Treatment

Papers in

Orthopedics and Sports Medicine 11
- Bone health and osteoporosis research 7
- Bone and Joint Diseases 4
Oncology 32
- Bone health and treatments 28

Co-authors: Knut A. Jaeggi Klaus Müller Laetitia Devy Stephan Ruetz Jeanette M. Wood Vincent Castronovo Karine Bonjean Akeila Bellahcène
Journals: Biochemical Society Transactions (4 papers)Journal of Bone and Mineral Research (2 papers)Bone (2 papers)Journal of Pediatric Gastroenterology and Nutrition (2 papers)Seminars in Oncology (2 papers)
Partner nations: Switzerland United Kingdom United States

In The Last Decade

Jonathan R. Green

40 papers receiving 3.1k citations

Hit Papers

align trajectories log scale

Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic Acid 2002 · 656 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2002 Journal of Pharmacology and Experimental Therapeutics

Peers

Countries citing papers authored by Jonathan R. Green

Since Specialization

Citations

This map shows the geographic impact of Jonathan R. Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan R. Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan R. Green more than expected).

Fields of papers citing papers by Jonathan R. Green

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan R. Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan R. Green. The network helps show where Jonathan R. Green may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan R. Green, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan R. Green Line = papers co-authored together Jonathan R. Green links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Zoledronate Bone ·Ian R. Reid, Jonathan R. Green, Kenneth W. Lyles, David M. Reid, U. Trechsel, David Hosking, Dennis M. Black, Steven R. Cummings, R.G.G. Russell, Erik Fink Eriksen	2020	47
2	A General Strategy for Targeting Drugs to Bone Angewandte Chemie International Edition ·Wolfgang Jahnke, Guido Bold, Andreas L. Marzinzik, Silvio Ofner, Xavier Pellé, Simona Cotesta, Juan Manuel Martínez Vázquez, Sylvie Lehmann, Alvaro Rojas Guzmán, René Hemmig, Frédéric Stauffer, Hua Shi, Jonathan R. Green, Jean‐Michel Rondeau	2015	22
3	Gezielte Anreicherung von Wirkstoffen am Knochen am Beispiel von allosterischen FPPS‐Inhibitoren Angewandte Chemie ·Wolfgang Jahnke, Guido Bold, Andreas L. Marzinzik, Silvio Ofner, Xavier Pellé, Simona Cotesta, Juan Manuel Martínez Vázquez, Sylvie Lehmann, Alvaro Rojas Guzmán, René Hemmig, Frédéric Stauffer, Hua Shi, Jonathan R. Green, Jean‐Michel Rondeau	2015	2
4	The Chemistry of Bisphosphonates: From Antiscaling Agents to Clinical Therapeutics Anti-Cancer Agents in Medicinal Chemistry ·Leo Widler, Wolfgang Jahnke, Jonathan R. Green	2012	20
5	The backbone of progress – preclinical studies and innovations with zoledronic acid Critical Reviews in Oncology/Hematology ·Jonathan R. Green, Andreas Guenther	2011	31
6	Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery Nature Chemical Biology ·Wolfgang Jahnke, Jean‐Michel Rondeau, Simona Cotesta, Andreas L. Marzinzik, Xavier Pellé, Martin Geiser, André Strauss, Richard BONNET, Francis Bitsch, René Hemmig, Chrystèle Henry, Sylvie Lehmann, J. Fraser Glickman, Thomas P. Roddy, Steven J. Stout, Jonathan R. Green	2010	106
7	Structural Basis for the Exceptional in vivo Efficacy of Bisphosphonate Drugs ChemMedChem ·Jean‐Michel Rondeau, Francis Bitsch, Juan Manuel Martínez Vázquez, Martin Geiser, René Hemmig, M. Kroemer, Sylvie Lehmann, Paul Ramage, 公三浅里, André Strauss, Jonathan R. Green, Wolfgang Jahnke	2006	187
8	A single intravenous administration of zoledronic acid prevents the bone loss and mechanical compromise induced by aromatase inhibition in rats Bone ·Jürg A. Gasser, Jonathan R. Green, Victor Shen, C Ottaviani, Elrasheed H. A. Mohammed, Ajay S. Bhatnagar, Dean B. Evans	2006	18
9	Skeletal complications of prostate cancer: Pathophysiology and therapeutic potential of bisphosphonates Acta Oncologica ·Jonathan R. Green	2005	19
10	Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen‐induced arthritis Arthritis & Rheumatism ·Natalie A. Sims, Jonathan R. Green, Markus Glatt, Baoyi Huang, T. John Martin, Matthew T. Gillespie, E. Romas	2004	107
11	Bisphosphonates: new therapeutic agents for the treatment of bone tumors Trends in Molecular Medicine ·Dominique Heymann, Benjamin Ory, F. Gouin, Jonathan R. Green, Françoise Rédiní	2004	109
12	Use of REMI andAgrobacterium-mediated transformation to identify pathogenicity mutants of the biocontrol fungus,Coniothyrium minitans FEMS Microbiology Letters ·Christopher W. Rogers, Michael P. Challen, Jonathan R. Green, John M. Whipps	2004	49
13	Antitumor effects of bisphosphonates Cancer ·Jonathan R. Green	2003	262
14	Bisphosphonates in cancer therapy Current Opinion in Oncology ·Jonathan R. Green	2002	35
15	Highly Potent Geminal Bisphosphonates. From Pamidronate Disodium (Aredia) to Zoledronic Acid (Zometa) Journal of Medicinal Chemistry ·Leo Widler, Knut A. Jaeggi, Markus Glatt, Klaus Müller, Monika R Fleshner, Carolina Sharlym Alcalde Takano, Ezequiel S.de Sousa, Reto Cortesi, Agustina Butar Butar, 深雪久保, Geraldine Honnet, 浩爾中北, Johann Schmid, P. S. MELLORf, J. Kleffe, Jonathan R. Green	2002	266
16	Pharmacologic profile of zoledronic acid: A highly potent inhibitor of bone resorption Drug Development Research ·Jonathan R. Green, Michael J. Rogers	2002	78
17	Preclinical pharmacology of zoledronic acid Seminars in Oncology ·Jonathan R. Green	2002	39
18	Amino-Substituted GEM-Bisphosphonates Phosphorus, sulfur, and silicon and the related elements ·Leo Widler, Knut A. Jaeggi, Jonathan R. Green	1999	14
19	Renal Tolerability Profile of Novel, Potent Bisphosphonates in Two Short‐Term Rat Models Pharmacology & Toxicology ·Jonathan R. Green, J. Kleffe, Knut A. Jaeggi, Leo Widler	1997	77
20	Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: A comparative histomorphometric study on the cancellous bone formed before, during, and after treatment The Anatomical Record ·A. Pataki, Klaus Müller, Jonathan R. Green, Fei Yan, Hal Vogel, W.S.S. Jee	1997	99

About Jonathan R. Green

Jonathan R. Green is a scholar working on Orthopedics and Sports Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Nutrition and Dietetics and Pulmonary and Respiratory Medicine, having authored 41 papers that have together received 3.2k indexed citations. Recurring topics across this work include Bone health and treatments (28 papers), Radiopharmaceutical Chemistry and Applications (19 papers), Bone health and osteoporosis research (7 papers), Bone Metabolism and Diseases (5 papers), Infant Nutrition and Health (4 papers), Bone and Joint Diseases (4 papers), Medical Imaging and Pathology Studies (4 papers) and Medical Imaging Techniques and Applications (3 papers). The work is most often cited by research in Orthopedics and Sports Medicine (1.1k citations), Oncology (2.4k citations), Radiology, Nuclear Medicine and Imaging (791 citations), Rheumatology (338 citations) and Pulmonary and Respiratory Medicine (526 citations). Jonathan R. Green has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include Knut A. Jaeggi, Klaus Müller, Laetitia Devy, Stephan Ruetz, Jeanette M. Wood, Vincent Castronovo, Karine Bonjean, Akeila Bellahcène, Jean Michel Foidart and Michael J. Rogers. Their work appears in journals such as Biochemical Society Transactions, Journal of Bone and Mineral Research, Bone, Journal of Pediatric Gastroenterology and Nutrition and Seminars in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact